QuilliChew ER is a central nervous system stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). QuilliChew ER is a chewable tablet taken by mouth.
It is not known if QuilliChew ER is safe and effective in children under 6 years of age.
QuilliChew ER is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep QuilliChew ER in a safe place to prevent misuse and abuse. Selling or giving away QuilliChew ER may harm others and is against the law.
Remember to always follow your child’s healthcare provider's orders, including how much medication should be taken and directions when changing the dose. QuilliChew ER should be taken exactly as prescribed.
IMPORTANT: Before taking QuilliChew ER, tell your or your child’s healthcare provider about all health conditions (or a family history of), including heart problems, mental problems, circulation problems, if you or your child are pregnant or plan to become pregnant, or if you or your child are breastfeeding or plan to breastfeed. Also tell your or your child’s healthcare provider about any other medications you or your child are taking.
* In a clinical study performed in a laboratory classroom, QuilliChew ER was found effective at reducing the symptoms of ADHD in children ages 6-12 years compared to a sugar pill at 45 minutes and 2, 4, and 8 hours after taking.
** Co-pay offer is subject to eligibility. Terms and Conditions apply.
† Mobile Terms and Conditions: coupon.trisadhd.com/terms. Message data rates may apply.